Article Text

Download PDFPDF
Blood pressure measurements for treating hypertension: which method counts the most?
  1. Carl J Lavie,
  2. Richard V Milani,
  3. Hector O Ventura
  1. The John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana, USA
  1. Correspondence to Dr Carl J Lavie, John Ochsner Heart and Vascular Institute, Ochsner Clinical School - The University of Queensland School of Medicine, New Orleans, LA 70121-2483, USA; clavie{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Considerable recent attention has been directed at the assessment and treatment of elevated levels of blood pressure (BP) in patients with hypertension (HTN). Although most of this emphasis has focused on exactly what level of BP requires treatment, an equally important question is what BP measurements should be used to determine optimal BP level and control.1 If blood pressure treatment is based on office BP readings, should this be based on a single BP assessment, which is commonly used in most busy clinical practices, or should this be based on the average of several readings and possibly by the average BP based on several measurements performed after the very initial measurement?

In their Heart paper, Burkard et al2 assessed 1000 adult subjects and compared the first office BP measurement to the mean of the second to fourth measurements. Relative to the average BP measurements and the single initial measurement, a high percentage of patients had substantial differences in systolic BP and diastolic BP that could influence clinical management. In fact, over half of patients …

View Full Text


  • Contributors CJL, RVM, HOV.

  • Funding This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

  • Competing interests None declared.

  • Patient consent Not required.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • Cardiac risk factors and prevention
    Thilo Burkard Michael Mayr Clemens Winterhalder Licia Leonardi Jens Eckstein Annina Salome Vischer